News zum Sektor Gesundheit aus Kanada

 

Calgary, Alberta--(Newsfile Corp. - July 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual finan......

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, ON / AC......

LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and ch......

Collaboration combines more than 9,000 KetaMist patient treatments with PharmaTher's prior FDA-approved ketamine experiencePursuing an efficient FDA development pathway toward approval for treatme......

Vancouver, BC, July 21, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI" or the "Company") today announced that its wholly owned digital health platform and marketplace subsidiary, Rocket Doctor Inc., has joined the Alliance for Connected Care's Telehealth Voters Pledge, a growing national coalition advocating for permanent Medicare telehealth legislation in the United States....

Canopy Wave is a leading U.S. AI inference platform powering high-performance, cost-efficient open-weight model deployment for enterprise developers and AI labs nationwideUnder the definitive agree......

Vancouver, British Columbia--(Newsfile Corp. - July 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is providing a corporate upd......

Während Novo Nordisk Milliarden in eigene Aktien steckt, öffnet sich in Kanada die Tür für erste Nachahmerprodukte zu Ozempic....

Die AbCellera-Aktie hat nach ihrer starken Aufwärtsbewegung zuletzt eine gesunde Korrektur eingelegt und damit einen Teil der vorherigen Gewinne abgegeben. Nun richtet sich der Blick der Anleger erneut auf die Charttechnik. Gelingt der Aktie die Fortsetzung des übergeordneten Aufwärtstrends, könnte sich aus charttechnischer Sicht ein Kurspotenzial von bis zu +250% ergeben. Entscheidend wird sein, ob […] The post AbCellera-Aktie nach Rücksetzer mit +250% Potenzial? first appeared on sharedeals.de....

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES....

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 30,330 common shares of the Company (the "Options") with effective grant dates of July 20, 2026. The Options have an exercise price equal to the closing price of Definium's common shares on the date of the grants, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in substantially equal monthly increments over the three-year period thereafter, subject to each employee's continued employment. The Options were granted as a material inducement to each employee's employment and were approved by Definium's Compe...

BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility....

  Ventripoint's VMS+ platform to be evaluated alongside a second AI technology in a landmark NHS study exploring earlier detection of chemotherapy-related heart damage   Toronto, Ontario – TheNewswire – July 20, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a leader in the application of artificial intelligence to echocardiography, today announced that its VMS+ technology has been selected for use in AIRES (Artificial Intelligence Reconstruction of Echocardiography Study), a newly launched clinical research study at The Royal Wolverhampton NHS Trust (RWT) in the United Kingdom.   AIRES is described as a world-first study evaluating AI-enabled echocardiography specifically in oncology patients. The research will focus on patients undergoing chemotherapy for breast cancer, a population at risk of developing treatment-related heart complications. The study will include more than 500 patients.   The study will assess whether AI-bas...

Guelph, Ontario--(Newsfile Corp. - July 20, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that it has engaged IMPAQ Capital Inc. ("IMPAQ"), an i......

Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use Disorder (“AUD”), addiction, and weight management, today announced the filing of a patent application with the Hong Kong Patent Office for innovative psychedelic compounds targeting the treatment of Post-Traumatic Stress Disorder (“PTSD”) and other mental health disorders....

Vancouver, British Columbia--(Newsfile Corp. - July 20, 2026) - Platauro Metals Corp. (TSXV: PURO) (formerly "Mexican Gold Mining Corp.") ("Platauro" or the "Company") is pleased to announce the s......

Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - QScreen AI Inc. (CSE: QAI) (OTC: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") today announced completion of the tiered screening architecture......

VANCOUVER, British Columbia, July 20, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada's leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, is pleased to announce that it will hold its Annual General Meeting (the “Meeting”) of shareholders at 9:00 AM PT on September 24, 2026 in person at the offices of Borden Ladner Gervais LLP, 200 Burrard St #1200, Vancouver, BC V7X 1T2....

Vireo Growth, through its subsidiary, Vireo Health of Arcadia, announced a definitive purchase agreement to acquire certain assets from The Cannabist Co....

MINNEAPOLIS, July 17, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that it has completed its previously announced acquisition of all of the issued and outstanding limited liability company membership interests of FarmX, LLC d/b/a PhytoNatural ("PhytoNatural"), jointly with Vive Penn, LLC ("Vive"), a joint venture between the Company and Hive Holdings, Inc., pursuant to the previously announced Securities Purchase Agreement (the "SPA") (the "PhytoNatural Transaction"). The acquisition includes a non-operational Pennsylvania medical cannabis retail permit that, subject to applicable regulatory approvals, authorizes the operation of up to six dispensaries in the Commonwealth....